Markets

Commodities

Currencies

Dyne Therapeutics Receives Orphan Drug Designation in Japan for Zeleciment Basivarsen for Myotonic Dystrophy Type 1

Dyne Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference

Dyne Therapeutics Appoints Vikram Karnani to Board of Directors

loader